Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
GRAIL, Inc., a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. It is also developing minimal residual disease and other post-diagnostic tests. The company was incorporated in 2015 and is based in Menlo Park, California. GRAIL, Inc. operates as a former subsidiary of Illumina, Inc. more
Time Frame | GRAL | Sector | S&P500 |
---|---|---|---|
1-Week Return | 4.22% | -3.72% | -0.05% |
1-Month Return | 62.43% | -1.85% | 2.75% |
3-Month Return | 61.85% | -11.4% | 7.4% |
6-Month Return | 11.91% | -4.41% | 10.47% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | - | - | 14.61M | 55.55M | 93.11M | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":15.69,"profit":true},{"date":"2022-12-31","value":59.66,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 10.31M | - | 114.61M | 172.00M | 188.72M | [{"date":"2019-12-31","value":5.46,"profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":60.73,"profit":true},{"date":"2022-12-31","value":91.14,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | (10.31M) | - | (100.00M) | (116.45M) | (95.61M) | [{"date":"2019-12-31","value":-1030700000,"profit":false},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-10000300000,"profit":false},{"date":"2022-12-31","value":-11644700000,"profit":false},{"date":"2023-12-31","value":-9561100000,"profit":false}] |
Gross Margin | - | - | (684.39%) | (209.63%) | (102.69%) | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-684.39,"profit":false},{"date":"2022-12-31","value":-209.63,"profit":false},{"date":"2023-12-31","value":-102.69,"profit":false}] |
Operating Expenses | 243.16M | 318.26M | 1.17B | 626.01M | 1.42B | [{"date":"2019-12-31","value":17.13,"profit":true},{"date":"2020-12-31","value":22.42,"profit":true},{"date":"2021-12-31","value":82.08,"profit":true},{"date":"2022-12-31","value":44.09,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | (253.46M) | (316.30M) | (1.27B) | (742.46M) | (1.52B) | [{"date":"2019-12-31","value":-25346300000,"profit":false},{"date":"2020-12-31","value":-31629500000,"profit":false},{"date":"2021-12-31","value":-126534200000,"profit":false},{"date":"2022-12-31","value":-74245900000,"profit":false},{"date":"2023-12-31","value":-151538200000,"profit":false}] |
Total Non-Operating Income/Expense | 20.84M | - | - | 3.24M | 15.70M | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":15.55,"profit":true},{"date":"2023-12-31","value":75.33,"profit":true}] |
Pre-Tax Income | (245.05M) | (312.12M) | (1.27B) | (5.44B) | (1.51B) | [{"date":"2019-12-31","value":-24505000000,"profit":false},{"date":"2020-12-31","value":-31212300000,"profit":false},{"date":"2021-12-31","value":-126525200000,"profit":false},{"date":"2022-12-31","value":-544138800000,"profit":false},{"date":"2023-12-31","value":-150763600000,"profit":false}] |
Income Taxes | (195.00K) | 33.00K | (17.48M) | (42.29M) | (41.95M) | [{"date":"2019-12-31","value":-590.91,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-52960.61,"profit":false},{"date":"2022-12-31","value":-128151.52,"profit":false},{"date":"2023-12-31","value":-127124.24,"profit":false}] |
Income After Taxes | (244.85M) | - | - | (5.40B) | (1.47B) | [{"date":"2019-12-31","value":-24485500000,"profit":false},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-539909800000,"profit":false},{"date":"2023-12-31","value":-146568500000,"profit":false}] |
Income From Continuous Operations | (244.85M) | - | - | (5.40B) | (1.28B) | [{"date":"2019-12-31","value":-24485500000,"profit":false},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-539909800000,"profit":false},{"date":"2023-12-31","value":-128365200000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (244.85M) | (312.16M) | (1.25B) | (5.40B) | (1.47B) | [{"date":"2019-12-31","value":-24485500000,"profit":false},{"date":"2020-12-31","value":-31215600000,"profit":false},{"date":"2021-12-31","value":-124777500000,"profit":false},{"date":"2022-12-31","value":-539909800000,"profit":false},{"date":"2023-12-31","value":-146568500000,"profit":false}] |
EPS (Diluted) | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
GRAL | |
---|---|
Cash Ratio | 9.05 |
Current Ratio | 9.65 |
Quick Ratio | 9.43 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
GRAL | |
---|---|
ROA (LTM) | 0.00% |
ROE (LTM) | 0.00% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
GRAL | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.17 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.83 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
GRAL | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 6.33 |
P/B | 0.29 |
Price/FCF | NM |
EV/R | 0.00 |
EV/Ebitda | NM |
GRAIL, LLC (GRAL) share price today is $22.74
Yes, Indians can buy shares of GRAIL, LLC (GRAL) on Vested. To buy GRAIL, LLC from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in GRAL stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of GRAIL, LLC (GRAL) via the Vested app. You can start investing in GRAIL, LLC (GRAL) with a minimum investment of $1.
You can invest in shares of GRAIL, LLC (GRAL) via Vested in three simple steps:
The 52-week high price of GRAIL, LLC (GRAL) is $23.78. The 52-week low price of GRAIL, LLC (GRAL) is $12.33.
The price-to-earnings (P/E) ratio of GRAIL, LLC (GRAL) is
The price-to-book (P/B) ratio of GRAIL, LLC (GRAL) is 0.29
The dividend yield of GRAIL, LLC (GRAL) is 0.00%
The market capitalization of GRAIL, LLC (GRAL) is $744.59M
The stock symbol (or ticker) of GRAIL, LLC is GRAL